Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NL-OMON29496Not yet recruiting
Open-label, single-arm trial in Infectious disease, sponsored by MRace. Primary endpoint: Prevalence of pharmacodynamic target attainment. Planned start May 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NL-OMON29496.